DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20204268

Sarcoidosis presenting as Lofgran’s syndrome

Atiullah Imran Malik, Kshithija Sajjan, Parati Rupesh Shivkumar, Vijayashree S. Gokhale

Abstract


A 40 year old male, first presented with erythema nodosum, fever, weight loss and joint pains and did not respond to anti-tubercular treatment. One year later he came back with joint pains, erythema nodosum, fever and dry cough. He also had weakness in distal right lower limb more than left limb. He had raised ESR, hypocalcaemia, raised ACE levels and lymphnode involvement on HRCT, with skin biopsy suggestive of sarcoidosis. This time patient responded to treatment and is on regular follow up.


Keywords


Erythema nodosum, Hypercalcemia, ACE levels, Sarcoidosis

Full Text:

PDF

References


Baughman RP, Elyse E. Lower: sarcoidosis. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Lozcalzo J, eds. Harrison’s principle of internal medicine, 20th ed. New York: McGraw-Hill; 2018:2600-06.

Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, et al. Course and prognosis of sarcoidosis around the World. Am J Med. 1974;57:847-52.

Löfgren, S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand. 1946;124:1-197.

Baughman RP, Teirstein AS, Judson MA. Clinical characteristics of patients in a case control study of sarcoidosis. Am J RespirCrit Care Med. 2001;164:1885-9.

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Quernheim JM. Sarcoidosis. Lancet 2014;383:1155-67.

Ungprasert P, Crowson CS, Matteson EL. Characteristics and long term outcome of neurosarcoidosis: a population-based study from 1976-2013. Neuroepidemiology. 2017;48(3-4):87-94.

Stern BJ, Royal W, Gelfand JM, Clifford DB, Tavee J, Pawate S, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group. JAMA Neurol. 2018;75(12):1546-53.

Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc. Diffuse Lung Dis. 2012;29:119-27.

Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950–1982. Epidemiology and clinical picture. Sarcoidosis. 1990;7:50-7.

Baughman RP, Field S, Costabel U, Crustal RG, Culver DA, Drent M, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016;13:1244–52.

Bhagwat B, Thyagaraj V. Coexistence of sarcoidosis and tuberculosis presenting with severe pulmonary artery hypertension: a clinical dilemma. Journal of Advances in Medicine and Medical Research. 2018; 26(7):1-6.

Rana S, Kaur R, Nirmal CK, Nishanth PS. A case of pulmonary sarcoidosis misdiagnosed as tuberculosis. J Assoc Chest Physicians. 2018;6:65-7.

Sharma SK, Moha A. Sarcoidosis: Global scenario & Indian perspective literature review. The Indian Journal of Medical Research. 2003;116:221-47.

Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. WASOG. 2001;18(1):70-4.

Babu K. Sarcoidosis in tuberculosis-endemic regions: India. J Ophthalmic Inflamm Infect. 2013; 3:53.

Agarwal R, Gupta D. Tuberculous sarcoidosis: Is it a separate entity?. Lung India. 2009;26(3): 61-2.

Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51.

Ungprasert P, Ryu JH, Matteson EL. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358-375.

Cottin V, Müller J. Quernheim Sarcoidosis from bench to bedside: a state-of-the-art series for the clinician. European Respiratory Journal. 2012;40:14-6.

Sauer WH, Stern BJ, Baughman RP, Culver DA, Royal W. High-Risk Sarcoidosis. Current Concepts and Research Imperatives. Ann Am Thorac Soc. 2017;14(Supplement 6):S437-44.